亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫藥中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 己酰基四肽-3Caprooyl Tetrapeptide-3
己酰基四肽-3Caprooyl Tetrapeptide-3
單價 10.00 / g對比
銷量 暫無
發貨 四川成都市付款后3天內
庫存 10000g起訂1g
品牌 成都云希
INCI Caprooyl Tetrapeptide-3
外觀 白色粉末
功效 皮膚護理
過期 長期有效
更新 2021-07-05 16:42
 
詳細信息

1.Basic information:

INCI Name: Caprooyl Tetrapeptide-3

Reference: ChronOline

Formula:

Molecular:

Purity: >95%

Grade: cosmetic

Source : synthetic

Formulation: available for your reference, please contact us.

MSDS and COA: available for your reference, please contact us.

Delivery: promptly from stock

Additive:

- Intensive treatment: 2.5%

- Preventive treatment: 1% to 2.5%

- Skin repair treatment: 0.3% to 1%

Appearance: white powder

 

2.Functions: 

1. Caprooyl Tetrapeptide-3 Reduces fine lines & wrinkles after 28 days

2. Caprooyl Tetrapeptide-3 Provides a continuous long term reduction of fine lines & wrinkles in mature skin

3. Caprooyl Tetrapeptide-3 Rejuvenates aging skin

4. Caprooyl Tetrapeptide-3 Makes the skin smoother, firmer, more even for a younger rested look

5. Caprooyl Tetrapeptide-3 Helps reduce the appearance of stretch marks

 

©2025 成都云希化工有限公司 版權所有   技術支持:化工網   訪問量:41480  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |